Phase
Condition
Stroke
Cerebral Ischemia
Treatment
Conventional therapy
SynPhNe platform
Clinical Study ID
Ages 21-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Ischemic or hemorrhagic stroke at least 6 months prior study enrollment ;
Moderate upper-extremity hemiparesis (initial score on the Upper ExtremityFugl-Meyer Assessment between 21 and 55 out of 66) ;
Ability to extend at least 2 fingers in the affected hand 10 degrees at any jointwith pain-free passive range of motion at least 50% in all joints below the elbow.
Exclusion
Exclusion Criteria:
Cognitive impairment resulting to inability to follow instructions (as assessed withthe MMSE) and inability to sustain attention for more than 10 minutes;
Current participation in upper-extremity therapy program;
Treatment with Botox injections in the affected arm in the previous 3 months and noplanned Botox injections before the end of the study;
Aphasia sufficient to limit comprehension and completion of the treatment protocol;
No more than moderate impairments in paretic UE sensation, passive range of motion,and pain that would limit ability to engage in therapy;
Increased muscle tone as indicated by score of >/= 3 on the Modified Ashworth Scale;
Previous diagnosis of dementia;
Previous diagnosis of neurological diseases other than Stroke;
History of seizures disorder and/or a seizure occuring within the last 6 months;
Other conditions affecting function of the stroke affected upper limb;
Severe pain in the stroke affected upper limb;
Terminal diseases with expected survival <1 year;
Study Design
Study Description
Connect with a study center
Spaulding Rehabilitation Hospital
Boston, Massachusetts 02129
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.